Home > Healthcare > Analytical Instruments > Immunoassay > Immunofluorescence Assay Market

Immunofluorescence Assay Market Trends

Report ID: GMI9818
Published Date: Jun 2024
Report Format: PDF

Download Free Sample

Immunofluorescence Assay Market Trends

Increased funding and focus on R&D in immunofluorescence have led to innovative solutions such as novel fluorescent dyes, advanced imaging techniques, and improved assay protocols.
Collaborations between academic institutions, research organizations, and industry players are accelerating the translation of basic research into commercially viable diagnostics. Ongoing clinical trials and studies are supporting broader adoption of IFAs, driving market growth.
Additionally, point-of-care testing which is estimated to reach USD 78.3 billion, provides rapid diagnostic results at patient care sites such as clinics, emergency rooms, and homes, is enhancing convenience and accessibility, thus stimulating its adoption. Point of care immunofluorescence assays enable quick, informed decision-making, particularly in emergency and critical care settings, reducing follow-up visits and hospitalizations, and lowering overall healthcare costs.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The market size of Immunofluorescence assay was reached USD 2.6 billion in 2023 and is estimated to grow at 5.1% CAGR from 2024 to 2032, owing to the increasing prevalence of chronic diseases.

The antibodies segment in the immunofluorescence assay market is predicted to hit USD 1.5 billion by 2032, as infectious diseases necessitate advanced diagnostics.

U.S. immunofluorescence assay market is projected to cross USD 1.5 billion by 2032, attributed to the rising incidence of chronic diseases in the U.S., such as cancer, autoimmune disorders, and infectious diseases.

Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Cell Signaling Technology, Inc., Danaher Corporation, EpigenTek Group Inc., MaxVision Biosciences Inc., Medipan GmbH, Merck & Co., Inc., J. Mitra & Co. Pvt. Ltd., Nikon Corporation, Olympus Corporation, and PerkinElmer, Inc., among others.